Clarity for Your MedTech Decisions
in a Fog of Data
In the medical device industry, every strategic choice is pivotal for achieving Sustainable Commercial Success. Yet, the most valuable market signals are often buried in fragmented Data Silos. Decision-making should not be a high-stakes gamble under information asymmetry.
Our Origin: A Shared Industry Dilemma
Amidst the opportunities and challenges of the medical device industry, a universal dilemma persists: the most valuable market signals are buried in data silos spanning the entire product lifecycle. From R&D and clinical trials to regulatory approval and post-market stages, the fragmentation of critical intelligence creates an "information fog" for decision-makers. This causes even the most brilliant innovations to miss crucial signals, leading them down long and costly detours.
~40 days
Faster 510(k) clearance for "expert-level" applicants vs. "novice-level."
~80 days
The efficiency gap widens in the competitive AI medical device field.
[1] Based on our data analysis.
Our Solution: IXI — The Cycle of Insight and Impact
At the core of IXI MedTech lies a powerful philosophy of intelligent circulation: The Cycle of Insight and Impact. It represents a complete value-added decision process, offering two complementary pathways.
Path 1: Impact-Driven
To achieve extraordinary commercial Impact, you need superior intelligence Insight to support sharper Decisions and more effective Actions. IXI MedTech starts with your business success as the goal, providing the Actionable Intelligence required to get there.
Path 2: Data-Driven
Conversely, when the destination is not yet clear, IXI offers a Data-Driven path of exploration. By extracting Insight from complex data, we help you discover potential decision paths and actions that can lead to significant impact.
IXI is more than a brand; it's an operational philosophy that connects cognition, decision, action, and results into a mutually reinforcing cycle, designed to empower MedTech decision-makers to accelerate innovation while mitigating risk. The core engine driving this philosophy is a unique suite of data analysis methodologies. Beginning with our successful pioneering application of the classic RFM analysis model to the field of medical device regulatory data, we continuously explore and integrate diverse analytical perspectives. For instance, we leverage Natural Language Processing (NLP) to deeply analyze the semantics of "Indications for Use," breaking through the granularity limitations of existing Product Codes. This is combined with "Predicate Device Network" analysis to deconstruct the evolutionary pathways and competitive moats of specific technologies. Our goal is to transform complex data into clear, commercially valuable strategic signals.
Our Vision
From Data Silos to Full-Lifecycle Intelligence
Our vision begins with a fundamental change: to completely break down the long-standing data silos in the medical device industry. We are building a unified intelligence engine that connects and integrates data across the entire medical device lifecycle: Pre-Approval, Approval, and Post-Approval.
Starting with FDA Clearance Data
We began with the vast and valuable data goldmine of FDA clearances. By innovatively applying our RFM analysis model, we have already proven the feasibility and immense value of turning regulatory data into commercial insights.
Toward a Panoramic Blueprint
In the future, we will integrate diverse data sources such as patents and clinical trials (Pre-Approval), global regulatory approvals (Approval), and adverse events and reimbursement data (Post-Approval).
Predict and Guide the Future
Ultimately, our goal is not just to present data, but to generate predictions and guide you to take actions that achieve Extraordinary Impact. This is the ultimate form of "decision intelligence" as we define it.
Who We Are: A Deep Fusion of Industry Wisdom and Data Science
Combining the regulatory Nuance of MedTech with the Scale of big data analytics requires a rare, cross-domain DNA. IXI MedTech is the embodiment of this belief, strategically co-created by two leading teams.
WISPRO
Our cross-disciplinary team deeply integrates expertise in medical device regulations, intellectual property, business strategy, and intelligence analysis—a skill set that precisely covers every critical decision point from "pre-approval" to "post-approval." We bring nearly 20 years of hands-on industry experience.
WISPRO's industry wisdom defines "what questions to ask."
Mavus
As our key technology partner, Mavus injects an exceptionally rare cross-domain DNA. Their team not only possesses top-tier software engineering capabilities but is also rooted in a deep clinical medicine background and practical experience in medical device distribution channels.
Mavus's data science provides "how to answer them at scale."
Our partnership is your key to seeing what others cannot.
An Invitation: Co-Create the Future of Decision-Making
IXI MedTech is at its starting point, and your professional insights are the most valuable fuel for refining our product. We cordially invite you to join our Beta Program. This is more than just a product trial; it's a journey to co-create the future of decision-making in the medical device industry.